NewcelX
Business Services · Switzerland · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Hohstrasse 1, Kloten, Zurich, 8302, Swit...Phone Number
+41 445122150Website
www.newcelx.comRevenue
$7.4 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About NewcelX
NewcelX is a biotechnology company focused on developing regenerative medicine and cell-based therapies for chronic and degenerative conditions. The company leverages advanced stem cell research and innovative treatment platforms to support tissue repair, healing and patient recovery through personalized and science-driven healthcare solutions.Explore more
NewcelX Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NewcelX your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
NewcelX, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if NewcelX has recently received funding, and reach out quickly before it becomes old news!
Check out if NewcelX is spiking on competitors!
Funding: Get notified immidiatlly once NewcelX has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if NewcelX had a recent Job posting/layoffs
Product Launch: Get notified when NewcelX launches new products
Congratulate Masked Content for being promoted to Masked Content at NewcelX
Earning: See what the market has to say on NewcelX recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined NewcelX as Masked Content
Find more new buyers
NewcelX financials insights
Gather financial insights about NewcelX, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Private Equity
$3.4M
NewcelX News & Media
NewcelX Appoints World-Renowned Diabetes Cure-Focused Pioneer, Dr. Camillo Ricordi, to Scientific Advisory Board
The appointment follows NewcelX's recently announced successful FDA Type B Pre-IND meeting for NCEL-101, providing a clear regulatory pathway toward clinical trialsNewcelX Announces Successful FDA Pre-IND Meeting with Clear Path Forward for NCEL-101 Toward Starting Clinical Trials for Type 1 Diabetes
FDA feedback supports NewcelX’s planned development strategy for NCEL-101 in combination with Tegoprubart FDA feedback supports NewcelX’s planned development strategy for NCEL-101 in combination with TegoprubartNewcelX Publishes Peer-Reviewed Study Demonstrating Broad Therapeutic Potential of its Stem Cell Technology Platform
Study published in Stem Cell Reports demonstrates that AstroRx® - a therapy derived from NewcelX’s platform - addresses key barriers to remyelination with potential to treat chronic demyelinating diseases including MS
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding NewcelX
Sign Up For FreeTo access detailed company insights
NewcelX is a biotechnology company focused on developing regenerative medicine and cell-based therapies for chronic and degenerative conditions. The company leverages advanced stem cell research and innovative treatment platforms to support tissue repair, healing and patient recovery through personalized and science-driven healthcare solutions.... Read More
